Get your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
159 Doctors Online

By proceeding, I accept the Terms and Conditions

Dr. Andrew Rynne
MD
Dr. Andrew Rynne

Family Physician

Exp 50 years

HCM Blog Instant Access to Doctors
HCM BlogQuestions Answered
HCM Blog Satisfaction

Is Opdivo Advisable For Metastatic Renal Cell Carcinoma?

I have metastic renal cell ca. I took votrient for two years and six month then had to stop it because of severe Weight loss .i also had radiation which did not seem to work.my oncologist is now considering the new drug Opdivo.what are your thoughts regarding the success of this drug. Thank you in advance for your input.
posted on Sat, 5 Dec 2015
Twitter Tue, 31 Mar 2020 Answered on
Twitter Wed, 1 Apr 2020 Last reviewed on
Report Abuse
General Surgeon,  's  Response
Hello,

* As per my surgical experience, the Opdivo ( Nivolumab ) is a monoclonal antibody originally approved for use in lung cancer , now used in variety of oncological disorders including that of metastatic melanoma, kidney cancer and others.

It is the immune modulation approach which helps your body cells of T and B group to fight against the cancer cells.

However, individual response depends upon multiple parameters and the same has to be evaluated considering pros and cons of the therapy side effects.

Hope I have answered your query. Let me know if I can assist you further.

Take care

Regards,
Dr. Bhagyesh V. Patel
I find this answer helpful
Note: For further follow up on related General & Family Physician Click here.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer. For a more detailed, immediate answer, try our premium service [Sample answer]
Share on
 

Related questions you may be interested in


Loading Online Doctors....
Is Opdivo Advisable For Metastatic Renal Cell Carcinoma?

Hello, * As per my surgical experience, the Opdivo ( Nivolumab ) is a monoclonal antibody originally approved for use in lung cancer , now used in variety of oncological disorders including that of metastatic melanoma, kidney cancer and others. It is the immune modulation approach which helps your body cells of T and B group to fight against the cancer cells. However, individual response depends upon multiple parameters and the same has to be evaluated considering pros and cons of the therapy side effects. Hope I have answered your query. Let me know if I can assist you further. Take care Regards, Dr. Bhagyesh V. Patel